Lenders high on Bayer with 70% oversubscription

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Lenders high on Bayer with 70% oversubscription

A tight 42.5bp margin on German pharmaceutical group Bayer’s Eu3.5bn five year loan did little to put off lenders as the deal closed 70% oversubscribed, according to bankers.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article